Stanford's Virtual Biotech Employs 37,000 AI Agents for Drug Discovery

This demonstrates a scalable and beneficial AI application in medicine that could significantly accelerate drug development processes.

Auto-scored: Low risk as it is a positive capability advance in healthcare, with high mitigation from a major beneficial development.